DGAP-News

Carl Zeiss Meditec AG grows in all business units - Seite 2

Surgical Ophthalmology SBU.

Based on the modified structure, the Microsurgery SBU increased its
revenue, on a comparable basis, by 4.6 percent to EUR 67.8 million
(previous year: EUR 64.8 million), which corresponds to growth of 2.6
percent, after adjustment for currency effects.

The revenue of the Ophthalmic Systems SBU in the new structure
(comparatively) climbed by 13.5 percent to around EUR 91.7 million,
compared with the previous year's figure of EUR 80.8 million, although the
area of diagnostics within this sector continues to be hampered by strong
pricing and competitive pressure, to which the Company shall respond in the
coming financial year with cost-cutting measures. Positive development was
achieved in this SBU in the areas of Refractive Lasers and Service.
Adjusted for currency effects, the SBU's revenue increased by 8.6 percent.

Once again the highest growth rate was achieved by the now newly assembled
Surgical Ophthalmology SBU. This SBU's revenue increased by 22.4 percent,
on a comparable basis, to around EUR 81.6 million (previous year: EUR 66.7
million). Even without taking into consideration the first-time
consolidation of Aaren Scientific Inc., Ontario, California, which
specializes in the manufacture of intraocular lenses, this SBU achieved an
organic growth rate well into the double-digit percentage range.

Development by region

EMEA (Europe, Middle East and Africa): In the EMA region, revenue increased
by 22.7 percent to EUR 86.5 million in the first three months (previous
year: EUR 70.5 million). As in prior quarters, development on the
individual markets is highly heterogeneous. Germany and the UK recorded
strong growth rates; revenue in Southern Europe recovered further - Spain
performed particularly well, due to purchases brought forward in reaction
to an impending VAT increase; business in Russia continues to decline.

Americas: Revenue in the Americas region increased by 4.0 percent, to EUR
80.6 million (previous year: EUR 77.6 million). This region benefited in
particular from the strength of the US dollar. Adjusted for currency
effects, the Americas would have recorded a revenue decline of 3.3 percent.

APAC (Asia/Pacific region): The APAC region achieved a revenue increase of
15.1 percent in the first quarter, to EUR 73.9 million (previous year: EUR
64.2 million). Adjusted for currency effects, growth was on a comparable
scale, at 16.2 percent. As in prior quarters, revenue in Japan continued to
decline after the sharp increase in value added tax in the previous year.
Substantial contributions to growth came from China and Australia.